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Abstract 
 
Petersson Grawé, K. 2003. Lactational transfer of cadmium in rodents – CNS effects in the 
offspring. Doctor’s dissertation. 
ISSN 1401-6257, ISBN 91 576 6371 8 
 
This thesis comprises studies on the transfer of cadmium (Cd) from the lactating dam to the 
suckling and CNS effects of Cd during development, using rodents as a model. The purpose 
has been to conduct low–level exposure studies relevant for risk assessment of Cd. 
Cadmium is recognised as a toxic environmental contaminant with renal dysfunction 
considered as the critical effect after long-term exposure. For the non-smoking, non-
occupationally exposed population, food, especially of vegetable origin, is the main source 
of cadmium exposure.  
Cd concentration in suckling pup kidney was strongly correlated with Cd in milk and 
kidney of the Cd exposed lactating rats, showing that cadmium is transferred to the pup via 
milk and absorbed in the suckling. This indicates that Cd in kidney can be used as a 
biomarker of the Cd dose in pups. A prominent uptake and retention of Cd was 
demonstrated in the mammary tissue, where Cd binding to metallothionein was indicated. 
Cd in milk was present mainly in the fat and casein fractions with a smaller part in the 
whey fraction. 
The serotonergic system in the developing brain was found to be susceptible to Cd. 
Hippocampal and cortical levels of serotonin and its metabolite, 5-hydroxyindoleacetic 
acid, were markedly reduced in animals exposed via milk. The exposure did not cause any 
detectable levels of Cd in the brain. A positive linear correlation was revealed between 
spontaneous locomotor activity and kidney cadmium concentrations in pups exposed via 
milk. There were no effects on learning, memory or anxiety due to treatment. 
Effects on the fatty acid composition after Cd exposure were found in the liver and milk 
of the dams, and a minor modification was detected in the brain of the pups. The long-chain 
polyunsaturated fatty acids, which are important for normal development of the CNS, were 
unaltered, as were zinc levels in the brain. Probably, the observed CNS effects are due to a 
direct effect of very low levels of Cd in the developing brain. 
The results indicate that neurochemical and neurobehavioral effects during development 
may be a more sensitive endpoint for cadmium toxicity than renal dysfunction. 
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postnatal, pollutant, heavy metal, toxic metal 
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Introduction 
 
This thesis comprises studies on the transfer of cadmium from the lactating dam to 
the suckling, and CNS effects of cadmium during development, using rodents as a 
model. Cadmium (Cd) is recognised as a toxic environmental contaminant (WHO, 
1992). For the non-smoking general population, food, especially of vegetable 
origin, is the main source of cadmium exposure (WHO, 2001).  
 
Normally, the main source of exposure to toxic compounds during the neonatal 
and first part of the infancy period is breast milk. This period is characterised by 
rapid growth and development of the nervous, immune, and 
endocrine/reproductive systems, which render the newborn more vulnerable than 
adults to harmful substances (Rice & Barone Jr, 2000). Also, kinetics during the 
neonatal period differs from that in adults, which may put the neonate at special 
risk (WHO, 1986). In risk assessment of chemical hazards, it is widely recognised 
that pregnant women and their foetuses are risk groups that need special attention. 
Compared to the well motivated interest in these established risk groups, very little 
attention has been paid to the susceptibility of the newborn.  
 
Lactation 
The lactating mammary gland 
The ability to feed the newborn with endogenously produced milk is an essential 
characteristic of mammals, and the development and structure of the mammary 
gland has been conserved during evolution (Gould, 1983). The secretory cells in 
the mammary gland are arranged in a single cell layer in alveoli surrounding an 
interior lumen, in which the synthesised milk is emptied. These cells are referred 
to as mammary epithelial, alveolar, or acinar cells. A network of blood vessels and 
myoepithelial cells surround each alveolus, the latter being contractile and 
responsible for the ejection of milk from the secretory cells into the lumen. The 
alveoli are arranged in clusters forming lobuli, each lobulus having a lactiferous 
duct in which the alveolar ductules empty the secreted milk. The lactiferous ducts 
all end up in the nipple where the milk is excreted. (Gould, 1983; Larson, 1985).  
 
Milk composition 
The composition of milk is complex, containing a large number of constituents. 
The major components are water, lipids, proteins, lactose and salts. Other 
important constituents are enzymes, hormones and immunoglobulins (Jensen, 
1995). Comparative studies have revealed marked differences in milk 
composition, but also common features between species (Davies et al., 1983). For 
instance, primate milk is rich in lactose and poor in protein and fat, while the 
relationship is the opposite in milk from marine mammals.  
 
The proteins in milk are mainly caseins and whey proteins (Jensen, 1995). 
Caseins are milk-specific phosphoproteins, which aggregate to micelles in the 
presence of calcium and phosphate (Jensen, 1995). The caseins can be separated 
by centrifugation and the resulting whey contains the soluble proteins. In human 6 
milk, Į-lactalbumin is the major whey protein, synthesised in the alveolar cells, 
and specific for milk (Jenness, 1985). Aside from being one component of the 
enzyme lactose synthase, Į-lactalbumin is considered a metalloprotein, having 
several binding sites for e.g. Zn
2+ (Permyakov et al., 2000). In ruminants, ȕ-
lactoglobulin is the most abundant whey protein (Jenness, 1985).  
 
The milk fat supplies energy, essential fatty acids, vitamins and other fat-soluble 
factors to the suckling (Neville, 2001). Most of the lipid consists of triglycerides, 
contained in fat droplets called milk fat globules (MFG). The fatty acid 
components are derived either from maternal diet or maternal storage or are 
synthesised de novo in the alveolar cells. An enzyme unique to the mammary 
alveolar cells, thioesterase II, terminates the elongation of the fatty acid after the 
addition of 8 -14 carbon atoms (Smith et al., 1983).  
 
Milk secretion 
Compounds are transported from plasma across the basolateral and mammary 
epithelial cells, out in the alveolar lumen by different pathways. The secretory 
mechanisms have been reviewed by (Linzell & Peaker, 1971; Larson, 1985; 
Shennan & Peaker, 2000; Neville, 2001). Water moves freely across the 
membranes in response to the osmotic gradient set up by lactose, which is 
synthesised in the cells. Sodium, potassium and chloride move across the 
membranes partly by active transport, and partly by moving freely following their 
electrochemical gradients. Secretory compounds like the major milk proteins and 
lactose, but also phosphorous and calcium are transported to, or sequestered by, 
the Golgi apparatus, packed into secretory vesicles and excreted into the lumen by 
exocytosis. The milk fat globules, containing milk lipids, increase in size as they 
move towards the apical membrane. There they bud off, sometimes together with 
small amounts of cytoplasm, encapsuled by fragments of the apical membrane 
(Kurosumi et al., 1968). This membrane is termed the milk fat globule membrane 
(MFGM). Blood immunoglobulins are transported through the secretory cells by 
specific intracellular transport mechanisms. These involve binding to receptors at 
the basolateral membrane, pinocytos, transport in vesicles, and finally exocytosis 
at the apical membrane. Tight junctions normally prevent passage of substances 
between the alveolar cells. During pregnancy, and during milk accumulation or 
mastitis in ruminants, the tight junctions become leaky and compounds in plasma 
can pass into the alveolar lumen (Stelwagen et al., 1997; Neville, 2001). 
 
Recently, the identification of transport proteins has improved the understanding 
of the secretory mechanisms in the mammary epithelial cells. For instance, the 
lactating mammary gland has a high demand for glucose which is the precursor for 
lactose and triacylglycerols (Shennan & Peaker, 2000). The GLUT1 glucose 
transporter is one identified mechanism for uptake of glucose across the 
basolateral membrane (Shennan & Peaker, 2000). Similarly there are transporter 
systems supplying the alveolar cells with amino acids and peptides (Groneberg et 
al., 2002). Increased mRNA levels for several transporter genes, e.g. organic 
cation transporter, multidrug resistance transporter, have been identified in 
lactating human mammary epithelial cells compared to non-lactating cells (Alcorn 
et al., 2002). A sodium dependent transporter of iodine on the basolateral 7 
membrane, and the presence of another transporter on the apical membrane has 
been identified (Spitzweg et al., 1998; Cho et al., 2000; Remilla et al., 2003). 
Iodine in the maternal diet is readily transferred across the mammary epithelial 
cells into milk, and may therefore be a matter of concern in cases of radioactive 
fallouts (Jensen, 1995). Another example is ZnT-4, which is highly expressed in 
the mammary epithelial cells, the protein being homologous to other known zinc 
transporters (Huang & Gitschier, 1997; Kelleher & Lönnerdal, 2002). In the lethal 
milk mutant mouse strain this gene is mutated, resulting in markedly less zinc 
secretion in milk and mortality of the suckling offspring (Piletz & Ganschow, 
1978; Lee et al., 1992). Mortality is prevented if the pups are nursed by dams of 
other strains, or given zinc orally (Ackland & Mercer, 1992).  
 
 
The developing central nervous system  
A period of rapid synthesis of brain tissue, commonly called the brain growth 
spurt, occurs during the last trimester and continues for about 18 months after 
birth in humans. In the rat, the brain growth spurt begins in the immediate 
postnatal period, with a peak at about 10 days of age. This period is characterised 
by e.g. formation of synaptic contacts and myelin synthesis (Innis, 1991). Brain 
development is a dynamic process varying in time and speed in different regions 
of the brain (Clandinin, 1999). During synaptogenesis, when interaction between 
neurons within and between brain regions is crucial, the neurons are sensitive to 
disturbances in their synaptic environment (Olney, 2002). Thus, each step in the 
development becomes a critical basis for development of the next. In addition, the 
blood-brain barrier limiting the uptake of compounds in the brain in adults is more 
permeable during development (Saunders et al., 1999). During development some 
of the neurotransmitters besides transmitting neuronal signals also regulate the 
development of neurones (Rice & Barone, Jr., 2000; Herlenius & Lagercrantz, 
2001; Nguyen et al., 2001). Thus, an insult having a transient effect on 
neurotransmitters in the adult brain may have permanent effects on the developing 
central nervous system. For example DDT, pyrethroids, organophosphates, 
nicotine, paraquat and PCBs have all been shown to cause irreversible behavioural 
and cholinergic changes in the central system in mice exposed during the brain 
growth spurt (Eriksson, 1997). 
 
Neurotransmitters and modulators 
The neurotransmitters in the central nervous system have important roles in 
normal functioning and behaviour of the adult individual. They interact with each 
other in complex networks, for instance in the processes of learning and memory, 
in which acetylcholine is proposed to have a central role (Decker & McGaugh, 
1991) and in locomotion for which e.g. dopamine and serotonin interact 
(Beninger, 1983; Oberlander et al., 1986). The serotonergic system is also 
involved in anxiety response as shown in animal studies (File et al., 2000). In 
animal models severe depletion of serotonin in cerebral cortex and hippocampus 
increases spontaneous activity, impairs learning and influences habituation 
(Mohammed et al., 1990). 8 
Neurotrophins include nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-5 (NT-5), and are 
present in peripheral and central neurons (Thoenen, 1995). Their function is not 
fully understood, but involves regulation of survival and differentiation of 
selective subsets of neurons, and maintaining normal function of neurons during 
adulthood (Thoenen, 1995). Also, BDNF seems to play a role in learning and 
memory processes (Tyler et al., 2002; Yamada et al, 2002). The neurotrophins 
bind and activate one or more of the tropomyosin-related kinase (Trk) family of 
receptor tyrosine kinases, thereby activating intracellular signalling pathways 
(Patapoutian & Reichardt, 2001). Alterations in BDNF and trkB mRNA have been 
reported after acute methylmercury and trimethyltin exposure (Andersson et al., 
1997a, Andersson et al., 1997b). BDNF and to some extent also NT-3 binds to 
trkB. Glial fibrillary acidic protein (GFAP) is considered a sensitive biomarker of 
neurotoxicity, being increased when astrocytes respond to tissue damage or 
exposure to chemicals like methylmercury or triethyltin (Eng et al., 2000).  
 
Fatty acids  
The brain lipid content is about 50-60% of the dry weight, most of the lipids being 
phospholipids (Sastry, 1985). During neonatal development a rapid accrual of 
long-chain polyunsaturated fatty acids (LCPUFA), especially arachidonic acid 
(AA) and docosahexaenoic acid (DHA), occurs in the brain (Innis, 1991; 
Clandinin, 1999).  
 
Fatty acids are aliphatic chains of carbons with a methyl group at one end of the 
chain and a carboxyl group at the other. The length of the carbon chain varies as 
does the number and localisation of double bonds between the carbon atoms. A 
few words about the nomenclature: fatty acids are commonly described by giving 
the number of carbons, followed by the number of double bonds, and finally the 
position from the methyl end (the n- or Ȧ-end) where the first double bond occurs, 
e.g. 20:4 (n-6). Fatty acids with 20 carbons are precursors for eicosanoid 
production in mammals, the most important being AA (Whelan, 1996). Except for 
the essential fatty acids, see below, fatty acids can be synthesised de novo, 
catalysed by a multienzyme complex, fatty acid synthase, present in several 
tissues. The predominant end product of de novo synthesis is palmitic acid, 16:0 
(Sastry, 1985). Besides de novo synthesis, fatty acids are also dietary derived.  
(Innis, 1991). In neonatal rodents it has been shown that EFA are transported to 
the brain by highly specialised mechanisms, while saturated and monounsaturated 
fatty acids are synthesised in the brain (Edmond et al., 1998). In brain, LA and 
LNA are metabolised to LCPUFA in astrocytes but not in neurons, as shown in 
primary cultures of rat neurons and astrocytes (Moore et al., 1991). 
 
Unlike plants, animals are unable to insert double bonds at n-6 and n-3 
positions, and can therefore not synthesise linoleic (LA), 18:2 (n-6) and linolenic 
acid (LNA), 18:3 (n-3). These are therefore essential fatty acids (EFA) in the 
human diet (Innis, 1991). EFA are precursors for LCPUFA, containing 20 or more 
carbons synthesised via several steps of desaturation and elongation, mainly in the 
liver (Innis, 1991; Voss et al., 1991; Sprecher et al., 1995) as shown in Figure 1. 
The enzymes active in the process of desaturation and elongation are common for   9 
18: (2 n-6)  
Linoleic acid (LA) 
 
∆-6 desaturase 
   
 
18:3 (n-6)  20:3 (n-6) 
 
∆-5 desaturase  
      
 
20:4 (n-6)   22:4 (n-6)  24:4 (n-6) 
 Arachidonic         
  acid  (AA)       ∆-6 desaturase 
        ∆-4 desaturase 
                   
 
22:5 (n-6)  24:5 (n-6) 
 
Figure 1a. Schematic presentation of the desaturation and elongation steps involved in the 
conversion of 18:2 (n-6) to 22:5 (n-6), two alternative pathways. Vertical and horizontal 
lines represent desaturation and elongation steps, respectively.  
 
 
18:3 (n-3)  
Linolenic acid (LNA) 
 
  ∆-6 desaturase 
 
18:4 (n-3)  20:4 (n-3) 
 
       ∆-5 desaturase 
 
20:5 (n-3)   22:5 (n-3)    24:5 (n-3) 
 Eicosapentaenoic        
 acid  (EPA) 
         ∆-6 desaturase 
           ∆-4 desaturase 
 
22:6 (n-3)  24:6 (n-3) 
      Docosahexaenoic  acid 
                     ( D H A )                
 
Figure 1b. Schematic presentation of the desaturation and elongation steps involved in the 
conversion of  18:3 (n-3) to 22:6 (n-3), two alternative pathways. Vertical and horizontal 
lines represent desaturation and elongation steps, respectively.  
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the n-6 and n-3 families of fatty acids, resulting in competition between LA and 
LNA for desaturation. A balance of the ratio n-6/n-3 in the diet is therefore 
important The fatty acids form larger molecules, of which the two main classes 
will be shortly described here. A triacylglycerol (also named triglyceride) consists 
of three fatty acids held in ester linkage to glycerol. Triacylglycerols are stored in 
droplets in the cytoplasm of many cells, and the function is mainly to store energy 
within the cell. Phospoholipids are the main constituents of cell- and intracellular 
membranes. They consist of one or two fatty acids, bound to phosphorylated 
alcohols, the phosphate group attached to a variety of small polar groups.  
 
The high levels of AA, 20:4 (n-6) and DHA, 22:6 (n-3) in the CNS and retina 
are important for normal function (Innis, 1991). In the cerebral cortex and retina 
the levels of DHA reaches about 50% of the total phospholipids. Animal studies 
have shown that diets low in EFA reduce brain AA and DHA levels, and there are 
indications of a correlation between learning impairment and reduced levels of AA 
and DHA (Yamamoto et al., 1987; Bourre et al., 1989; Enslen et al., 1991; 
Frances et al., 1996). Further, AA and its metabolites have been considered as 
possible candidates for messenger function in the formation of learning and 
memory in hippocampus (Katsuki & Okuda, 1995). Recent studies indicate that 
AA and DHA may play a role in dopamine and serotonin metabolism in EFA-
deficient piglets and rats (Delion et al., 1996; De la Presa Owens & Innis, 1999; 
De la Presa Owens & Innis, 2000). In piglets deficient in AA and DHA resulting 
in altered phospholipid composition in brain, levels of dopamine, serotonin and its 
metabolite hydroxyindoleacetic acid were decreased, a condition which was not 
seen after AA and DHA supplementation (De la Presa Owens & Innis, 1999). 
Breast milk supplies the neonate with EFA, AA and DHA. In human milk AA and 
DHA are present at concentrations <1% (Jensen et al., 1995).  
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Cadmium - an environmental contaminant 
The adverse health effect considered as the critical after long term exposure to 
cadmium is renal dysfunction (WHO, 2001). Recently, bone effects, i.e. decreased 
bone density and increased risk for fractures, have been raised as another possible 
adverse effect at environmental exposure levels (Staessen et al., 1999; Alfvén et 
al., 2000). Cadmium is also classified as a human carcinogen (IARC, 1993). Food, 
especially of vegetable origin, is the main source of cadmium exposure in the non-
smoking population. Exposure to cadmium via food is inevitable, since cadmium 
in the soil is readily taken up by plants (Hedlund et al., 1997). Uptake in plants 
depends on several factors besides levels of Cd in soil, like organic matter content 
in soil, pH in soil, species and variety (Öborn et al., 1995; Eriksson et al, 2000). 
Cadmium has a natural occurrence in soil, but there is also input from 
anthropogenic sources like atmospheric deposition and application of fertilisers of 
varying origin to agricultural soils (Hedlund et al., 1997; Lindén et al., 2003). 
Measures have been taken in an attempt to keep cadmium exposure on a safe level 
in food. Such measures are for instance reductions in cadmium emissions and 
regulations on maximum permitted levels in food and fertilisers (Hedlund et al., 
1997; EEC, 2001). The maximum levels for cadmium in food are based on a 
“Provisional Tolerable Weekly Intake” (PTWI) established by a Joint FAO/WHO 
Expert Committee (JECFA). The latest update resulted in a PTWI of 7 µg/kg body 
weight (WHO, 2001).  
 
Kinetics and metabolism 
In man, cadmium exposure occurs through ingestion or inhalation, ingestion being 
the dominating route in the non-smoking and non-occupationally exposed 
population (WHO, 2001). Data on gastrointestinal absorption in humans are 
limited, average absorption is reported to be 5% (WHO, 1992), but variations 
pending e.g type of diet is also observed (Sharma et al., 1983; Vahter et al., 1996). 
Female volunteers exposed to a single dose of stable cadmium isotope absorbed on 
average 11% of given cadmium dose, with a range of 2-18% (n = 14) (Vanderpool 
& Reeves, 2001). Higher cadmium levels in urine and blood in environmentally 
exposed females compared to males have been reported, indicating a higher 
gastrointestinal absorption in females (Buchet et al., 1990; Baecklund et al., 1999; 
Olsson et al., 2002). The gastrointestinal absorption of cadmium in animals is 
dependent on several factors like e.g species, cadmium dose and type of diet 
(Kello & Kostial, 1977; Engström & Nordberg, 1979a; Sasser & Jarboe, 1980; 
Lehman & Klaassen, 1986). Gastrointestinal absorption is also affected by age and 
neonatal and young mice have a higher absorption than adult rodents (Kello & 
Kostial, 1977; Engström & Nordberg, 1979b). Also calcium content in diets alter 
gastrointestinal absorption, calcium deprivation resulting in increased cadmium 
absorption and vice versa (Nordberg et al., 1985; Saric et al., 2002). Low iron 
status increases cadmium absorption in the gastrointestinal tract in rodents and in 
humans (Flanagan et al., 1978; Berglund et al., 1994; Schümann et al., 1996).  
 
Once absorbed, cadmium is transported in the blood mainly in the erythrocytes. 
Cadmium in plasma is initially bound to proteins with high molecular weight 
generally believed to be albumin, later a fraction is bound to a low molecular 12 
protein of the same size as metallothionein (MT) (Nordberg, 1978). MT is a group 
of small metalloproteins (6-7 kDa), rich in sulfhydryl groups, readily inducible, 
with a high affinity for essential and non-essential metals, like zinc, cadmium, 
mercury and copper. MT can bind up to 7 metals. Interaction between cadmium 
and zinc in the induction of MT is well established (Nordberg & Nordberg, 2000; 
Cherian, 1994). Of special importance is the MT induction in the liver, the Cd-MT 
complex being slowly released into plasma. Cd-MT in plasma is quickly cleared 
by the renal glomeruli and finally reabsorbed in the renal tubular cells, or excreted 
in the urine (Nordberg & Nordberg, 1988). Cadmium is selectively accumulated in 
the renal cortex and the liver, and it is estimated that up to 75% of the total 
cadmium body burden is present in these tissues. The biological half time for 
cadmium is extremely long, as it is estimated to be 10-30 years in human kidney 
cortex (WHO, 1992). In the kidneys Cd-MT is filtered through the glomeruli and 
reabsorbed in the proximal tubular cells. After degradation in lysosomes, the 
released cadmium ions induce synthesis of MT. When the synthesising capacity of 
MT is exceeded, cadmium will induce tubular dysfunction (Nordberg & Nordberg 
2000). 
 
The importance of MT in the kinetics and toxicity of cadmium is also proven by 
the fact that MT knockout mice, with no capacity to synthesise MT, show higher 
sensitivity to cadmium renal toxicity despite lower cadmium uptake in the kidney 
(Liu et al., 1998, 2000). Thus, MT protects from cadmium toxicity (Klaassen & 
Liu, 1998). The precise role of MT under physiological conditions has not been 
resolved yet (Palmiter, 1998). Besides protecting from cadmium toxicity, this 
highly conserved metalloprotein is suggested to be involved in the transport and 
storage of the essential metals zinc and copper, and it also acts as a free radical 
scavenger (Thornalley & Vasak, 1985; Min et al., 1991; Bauman et al., 1992; 
Dalton et al., 1994; Klaassen et al., 1999).  
 
Cadmium in brain – uptake and toxicity 
Cadmium uptake in brain is age dependent. In adult rats, there is a high cadmium 
uptake in choroid plexus, while only small amounts pass over to the cerebral 
compartment via choroid plexus (i.e. blood-cerebrospinal fluid barrier) or the 
blood brain barrier. This results in a low cadmium uptake in the brain parenchyma 
(Nordberg & Nishiyama, 1972; Arvidson & Tjälve, 1986; Takeda et al, 1999). In 
neonatal rodents there is also an uptake in choroid plexus, but cadmium uptake in 
brain is higher than in adults (Wong et al., 1980; Choudhuri et al., 1996), and 
appears to be related to the ontogeny of the brain vascular system (Valois & 
Webster, 1987). A long half life (i.e. >100 days) for cadmium in brain of neonates 
was also noted. 
 
Acute cadmium exposure to adult rats and mice causes hemorrhagic lesions in 
the sensory ganglia, but has no effect on the brain (Gabbiani et al., 1967a). In 
mice, considerable strain differences in sensitivity to cadmium toxicity in sensory 
ganglia are reported (Habeebu et al., 2001). Lesions in several regions of the brain 
and altered spontaneous activity have been reported after administration of a 
single, sublethal dose of cadmium to young rats (Wong & Klaassen, 1982; 
Ruppert et al., 1985). After chronic oral cadmium exposure the choroid plexus 13 
was degenerated in adult mice, resulting in increased protein content in the 
cerebrospinal fluid (Valois & Webster, 1989). Acute exposure to cadmium during 
the neonatal period on the other hand, results in hemorrhage, edema and necrosis 
within the brain (Gabbiani et  al., 1967b; Webster & Valois, 1981; Wong & 
Klaassen, 1982). The sensitivity to these profound effects seems to abruptly end at 
about 3 weeks of age in mice (Webster & Valois, 1981; Valois & Webster, 1987). 
Further, an increased expression of metallothionein in brain with age, and an 
inverse correlation between expression of metallothionein and cadmium 
accumulation in brain was shown in mice (Choudhuri et al., 1996). Thus, an 
undeveloped blood-brain barrier and a low expression of scavenging 
metallothionein may facilitate uptake and damage of cadmium to the developing 
brain. 
 
Changes in neurotransmitter metabolism in the central nervous system after 
cadmium exposure have been reported. Thus, high doses of cadmium to adult rats 
resulted in decreased brain levels of serotonin (5-HT), its metabolite 5-
hydroxyindoleacetic acid (5-HIAA) and acetylcholine (ACh) (Das et al., 1993). 
Changes in pup brain levels of 5-HT, dopamine (DA), noradrenaline (NA) or 
gamma-aminobutyric acid (GABA) have been reported after pre- and postnatal 
cadmium exposure (Rastogi et al., 1977; Gupta et al., 1993; Antonio et al., 1998; 
Gutiérrez-Reyes  et al., 1998; Lafuente et al., 2000; Esquifino et al., 2001). 
However, the changes are divergent, possibly explained by differences in 
experimental design like e.g. cadmium dose, timing in age at exposure and 
measurement of outcome, and brain regions investigated.  
 
Impaired learning performance in rodents has been reported after repeated 
cadmium exposure (Gupta et al., 1993). Lower repeated cadmium exposure 
resulted in increased locomotor activity in neonatal rats (Rastogi et al., 1977; 
Smith  et al., 1982). Also prenatal exposure to cadmium has been reported to 
change normal behaviour in rodents. Alterations in activity, delayed development 
of motor coordination and decreased learning have been demonstrated in offspring 
of dams orally exposed to low levels of cadmium during gestation (Ali et al., 
1986; Lehotzky et al., 1990). Pre- and postnatal cadmium exposure decreased 
exploratory behaviour and altered electrophysiological functions in pups 
(Nagymajtényi et al., 1997; Dési et al., 1998). 
 
To conclude, there are reports of cadmium induced neurobehavioral alterations 
during development, but the cadmium doses in several of these studies have been 
relatively high. In addition to behavioural effects, reduction in body weight gain 
are reported in some of the studies (Rastogi et al., 1977; Wong & Klaassen, 1982; 
Ruppert et al., 1985; Ali et al., 1986; Gupta et al., 1993; Nagymajtényi et al., 
1997).  
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Aims of the thesis 
 
The overall aim of the thesis was to increase the knowledge of cadmium 
distribution and adverse effects in the central nervous system, during lactation, and 
during early life in the offspring, using rodents as a model. The aim has also been 
to conduct low–dose exposure studies relevant for risk assessment of cadmium.  
 
More specifically, the aims were to study 
 
 
x  distribution of cadmium in the mammary gland and milk during lactation 
 
x  the milk transfer of cadmium and the uptake in the suckling pup 
 
x  neurochemical effects of cadmium after postnatal exposure via milk 
 
x  neurobehavioural effects of cadmium after postnatal exposure via milk 
 
x  possible mediators of CNS effects 
 
 
  
 
 
  
Materials and methods 
 
The methods used are described in detail in each paper. In this section a short 
overview of the methods is given. The animal experiments have been performed in 
line with the Swedish Animal Protection Act and approved by local ethical 
committees in Uppsala (paper I and II) or South Stockholm (paper III and IV). 
 
Animals and treatment 
All dams with litters were housed in separate cages. The animals were fed 
commercial pelleted diet and given tap water ad libitum. They were kept behind 
strict hygienic barriers at controlled temperature and humidity, with a 12:12 h light 
/dark cycle. The litter sizes were adjusted to eight pups per litter on the day of 
parturition (paper I and II), or day 4 after parturition (paper III and IV). In paper I, 
radioactive cadmium, 
109Cd was administered to lactating dams via intravenous 
infusion from osmotic minipumps to maintain constant and continuous cadmium 
exposure for 2 weeks. In paper II lactating dams with litters were exposed to 
cadmium as CdCl2 in drinking water at a dose of 5 mg Cd/l or control water. The 
pups were exposed to cadmium either during the suckling period via milk, during 
three weeks postweaning via drinking water, or during both periods. In paper III 15
and IV, lactating dams were exposed to cadmium as CdCl2 in drinking water at 
doses of 0, 5 or 25 mg Cd/l. During the suckling period the pups were exposed to 
cadmium exclusively via milk. Body weight, feed and water consumption was 
recorded in paper II, III and IV. In paper I body weights were recorded.  
 
Milking procedure 
In paper I and IV, milk was sampled from lactating dams. The pups were 
separated from the dams 2 h before milking to allow milk to accumulate in the 
mammary glands, and were returned to the dams when the milking was finished. 
The dams were anaesthetised with a mixture of Hypnorm (Janssen, Belgium) and 
Dormicum (Roche, Switzerland), 8.2 mg/kg body weight/ 4.1 mg/kg body weight 
respectively, administered intraperitoneally. To facilitate milk letdown a 
subcutaneous injection of 6.25 IU oxytocin/kg body weight (Syntocinon, 5 IU/ml, 
Sandoz, Basle, Switzerland) was given subcutaneously a few minutes prior to 
milking. From each dam approximately 2-3 ml milk was obtained by a milking 
device operated under vacuum as previously described (Oskarsson, 1987). 
 
Determination of cadmium and zinc 
Levels of radioactive cadmium, 
109Cd, in samples were determined using a gamma 
counter at the characteristic line of 88 keV photoemmision (paper I). When 
analysing non-radioactive cadmium and zinc, vessels and utensils were acid 
washed in order not to contaminate the samples. The tissues were dry ashed or 
digested in a microwave oven. Cadmium was determined by graphite furnace 
atomic absorption spectrometry (GFAAS), with Zeeman background and zinc by 
flame atomic absorption spectrometry (FAAS). In parallel with the samples in 
paper II, reference material of bovine liver was analysed. The results from 
cadmium analyses deviated from the certified concentrations, 0.78 ± 0.05 mg/kg 
w.w and 0.50 ± 0.03 mg/kg w.w, respectively. In parallel with the milk samples 
reference material, A11 milk powder from International Atomic Energy Agency 
(IAEA) was analysed. In paper III, reference materials, BCR 186 (pig kidney) and 
BCR 184 (bovine muscle), (Community Bureau of Reference, BCR, Brussels, 
Belgium) were run in each round of microwave digestion. The results were well 
within the 95% confidence interval of the certified value.  
 
Metallothionein 
In paper I, the relative binding of 
109Cd to the metallothionein (MT) in the 
cytosolic fraction was studied. Liver and mammary tissue were homogenised and 
centrifuged at 12 000 u g for 4 min. The supernatants were stored at –70 ºC before 
ultra-centrifugation at 100 000 u g for 2 h. The pellets and the ultra-centrifugation 
supernatants were analysed for radioactivity in the gamma counter. Proteins were 
separated by gel filtration on a Sephadex G-75 column. Fractions were analysed 
for radioactivity and the absorbance was measured at 280 nm.  
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Autoradiography 
In paper I, four lactating BSVS mice were injected intravenously with 
109CdCl2 in 
physiological saline (5 µCi/dam; specific activity 1.87 µCi/µg Cd) on day 13 of 
lactation. At 4, 24, and 72 h and 7 days after administration one dam and one pup 
from each litter were killed by exposure to CO2, embedded in carboxymethyl 
cellulose and frozen in hexane cooled with dry ice. Sagittal whole-body sections 
(20 µm) attached onto tape were taken through the whole animals in a cryostat at –
20 ºC as originally described by Ullberg (1977). The sections were freeze dried at 
–20 ºC and apposed against X-ray films at 4 ºC. The sections and films were 
separated and developed after 23 days for sections of dams and 9 months for 
sections of pups.  
 
Neurochemical tests 
In paper II, effects on monoaminergic and cholinergic transmitter systems as well 
as neurotrophins, and other markers of toxicity were characterised. Glial fibrillary 
acidic protein (GFAP), acetylcholinesterase (AChE), and tyrosine hydroxylase 
(TH) were studied by immunohistochemistry. Sections of hippocampus and 
cerebral cortex were stained with cresyl violet and examined using epifluorescence 
microscopy. In situ hybridization was used for identification of mRNAs for 
BDNF, NT-3 and trkB. Concentrations of neurotransmitters were determined after 
sonication and centrifugation of brain tissue. Acetylcholine (ACh) levels were 
measured using HPLC and electrochemical detection. Noradrenaline (NA), 
dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT), and 
5-hydroxyindoleacetic acid (5-HIAA) were separated on a reverse phase column 
and detected electrochemically.  
 
Behavioural tests 
In paper III behavioural tests were performed on rat pups exposed to cadmium via 
milk. Spontaneous locomotor behaviour was measured by placing the rats 
individually in plastic cages equipped with photobeams. The activity was 
measured by recording breakage of the beams during 6 consecutive periods of 10 
minutes. Small movement activity (repetitive breaking of the same beam), 
ambulation (breaking of consecutive beams), rearing (breaking of high level 
beams) and total activity (the sum of all counts) were recorded. A 
rotarod/treadmill was used for testing motor coordination. The animals were 
individually placed on a rotating rod, located 1 m above the floor. The time until 
the rat fell off the rod was registered. Learning and memory were tested in a water 
E-shaped maze. A hidden ladder was placed at the left arm and the rat was placed 
in the water in the central arm of the maze in a standardised manner. The time for 
the rat to locate the ladder and numbers of correct first choices were recorded. A 
week later the trial testing memory was conducted. The elevated plus-maze was 
used for testing of anxiety. The apparatus consists of 4 crossed arms, two being 
open and two being enclosed, placed about 0.65 m above the floor. The rat was 
placed in the centre of the maze, and the number of entries in open and closed 17 
arms, respectively, as well as the time the animal spent in the open and enclosed 
arms during a period of 5 minutes were recorded. The Morris water maze was 
applied as another way of testing learning. The rats were individually placed in a 
circular pool filled with tap water. A small platform was located 1 cm below the 
water surface, and the time for the rat to find the platform was recorded. Five 
consecutive trials were performed, each from a new starting point and the test was 
repeated for 3 consecutive days. 
 
Fatty acid analysis 
In paper IV lipids in milk, liver and brain were analysed for fatty acid 
composition. First, the lipids were extracted according to Hara & Radin (1978) 
using hexan:isopropanole. In the case of liver, the lipids were separated into 
membrane lipids, i.e., phospholipids, and triglycerides using preparative thin-
layer-chromatography. The solvent system used was hexane:diethylether:acetic 
acid 85:15:1. The fatty acids were converted to methyl esters (FAME) for further 
analysis by gas chromatography according to the methods of Dutta & Appelqvist 
(1989) and Appelqvist (1968). A fused silica capillary column was used for the 
separation of fatty acid methyl esters using helium as a carrier gas, using a flame 
ionization detector and split/splitless injector. The peak areas were identified by 
comparing the retention times with those of standard FAME samples.  
 
Statistics 
In paper I, II, and III, analysis of variance (ANOVA) was used for comparing the 
groups. If there were significant differences, Scheffé’s, Fisher’s or Tukey’s post 
hoc tests were applied. In the case of two groups only (paper II), Student’s t-test 
was applied. The data from the spontaneous locomotor activity test, Morris water 
maze and the E-maze (paper III) were tested by repeated measures ANOVA. 
Normality distribution was tested before analysis, and in papers III and IV also 
equality of variances. If the criteria for parametric methods were not fulfilled, the 
Kruskal Wallis test was used. In all papers, differences were considered 
statistically significant at p < 0.05. The statistical analyses have been conducted 
using software Minitab (Minitab Inc.) and StatView (SAS Institute, N.C., U.SA). 
  
 
Results and discussion 
 
Kinetics of cadmium in lactating rodents and their offspring  
In paper I, intravenous infusion was used in order to maintain a low and 
continuous cadmium exposure. In dams infused with cadmium from day 3 to day 
16 after parturition, cadmium levels increased in plasma and milk in a dose-
dependent manner, and were approximately twice as high on day 16 of lactation 
compared to day 10. The milk/plasma ratio varied between 2 and 6, indicating an 
active transport of cadmium from plasma to milk. Whole blood levels of cadmium were low. The proportion of cadmium in plasma in relation to whole blood ranged 
from 7% in the lowest dose group to 19% in the highest. The small amounts of 
cadmium available in plasma may partly explain the low levels of cadmium 
transferred to milk. For comparison, milk/plasma ratios of methylmercury, 
inorganic mercury and lead in rodents, after a single i.v. dose, were approximately 
0.10, 0.25 and 100, respectively (Palminger Hallén & Oskarsson, 1993; Sundberg 
et al., 1998). 
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Figure 2. Autoradiograms of lactating mice on day 13 of lactation, given an intravenous 
injection of 
109CdCl2 (5µCi) in saline and killed 24 h and 7 days later. At 24 h there is a 
high level of radioactivity (white areas) in liver, kidney cortex and mammary gland. A high 
uptake in the intestinal mucosa is also visible.The distribution pattern  is similar after 7 
days. 
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Cadmium exposure during lactation resulted in a considerable uptake and long 
retention of cadmium in the mammary tissue of rats and mice, in consistency with 
previous reports (Bhattacharyya et al., 1981, 1982). The uptake was rapid, as 
shown in lactating mice. Whole-body autoradiography after a single intravenous 
injection of tracer dose of 
109CdCl2 ( Figure 2a) showed a high uptake of 
radioactivity in liver, kidney, pancreas and mammary tissue. This pattern persisted 
7 days after exposure (Figure 2b). In the mammary gland the radioactivity was distributed in a non-uniform pattern 
with a high uptake in the epithelium of the lactiferous ducts and a low uptake in 
the lumen. Cadmium kidney concentrations of the suckling pups increased with 
dose, although the levels were 3 to 4 orders of magnitude lower than in the 
kidneys of the dams. A high correlation between cadmium concentrations in milk 
and kidney of pups was found, indicating that cadmium concentrations in pup 
kidneys could be used as a biomarker for cadmium exposure, despite the immature 
renal function. At 24 h and at 7 days after exposure of the dams, 
109Cd was present 
in the stomach and intestinal content and mucosa of the suckling pup (Figure 3a).  
 
 
 
Stomach content 
Kidney 
Intestinal content  
and mucosa  Kidney 
7d 
24h 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liver Stomach  Brain Intestinal   
content 
 
 
 
 
 
Figure 3. Details of autoradiograms of a suckling pup 24 h and 7 days after an 
intravenous injection of 
109CdCl2 (5 µCi) in saline given to the dam on day 13 of 
lactation. At 24 h a high level of radioactivity was observed in the stomach and 
intestinal content as well as in mucosa, but there was no radioactivity in the kidney 
or any other tissue. At 7 days uptake of radioactivity was observed in the kidney 
cortex and liver 
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This is in accordance with previously reported high cadmium uptake and retention 
in the intestinal mucosa of rodent pups during the suckling period (Eklund et al., 
2001; Brako et al., 2003). Retention of cadmium in the kidney cortex of suckling 
pups was observed in the autoradiograms at 7 days after exposure of the dams, 
indicating that cadmium accumulates in the proximal tubuli in the offspring as in 
the adult kidney (Figure 3b). Also the liver of the suckling pups had some uptake 
of radioactivity. Hepatic MT concentrations are higher in neonatal rodents 
compared to adults (Wong et al., 1980; Goering & Klaassen, 1984; Brako et al., 
2003), and probably cadmium is transported to the kidney complexed to MT, as 
shown in adult rodents (Nordberg & Nordberg, 2000). The proportion of 
radioactive cadmium eluted in the fraction with a similar molecular weight as 
metallothionein after gel filtration increased in a dose-dependent manner in 
mammary tissue (57 ± 11%, 73 ± 11%, 85 ± 3%), and in liver (88 ± 1%, 96 ± 1%, 
98 ± 1%) in control, low and high dose, respectively. In the liver cytosol the 
difference was statistically significant between all dose groups, while in the 
mammary gland the difference was significant between the high dose and control 
group only. Metallothionein has been found in mammary gland cells in non-
pregnant and pregnant guinea pigs and in mice (Nishimura et al., 1989; Lee et al., 
1992). It has also been shown that plasma levels of metallothionein increase in rats 
during gestation (Chan et al., 1993), and that metallothionein is induced in liver, 
kidney and duodenum in mice during lactation (Solaiman et al., 2001). A 
suggested reason for the observed MT induction during gestation and lactation is 
the increased demand for essential trace elements like zinc and copper, which also 
could result in the high uptake of cadmium in the mammary tissue. On the other 
hand, Brako and coworkers (2003) showed that cadmium uptake in mammary 
tissue as well as in the liver was higher in MTI/MTII knock-out mice compared to 
in wildtype mice. The high cadmium uptake in the liver and mammary gland of 
MT knockout mice may at least in part be explained by higher amounts of 
cadmium available in plasma. It is not known what cadmium is bound to in the 
tissues of the MT-knockout mice. Evidently there are other binding sites in liver 
and mammary gland, besides MT. By comparing the retention of cadmium in 
knock-out mice and wildtype mice it has been shown that MT plays a major role 
in the elimination of cadmium from other tissues than the kidney (Liu et al., 
1996). Also, at marginal zinc intakes in lactating rats, zinc concentrations in 
plasma, mammary gland, and milk were maintained, while mammary gland MT 
levels were decreased (Kelleher & Lönnerdal, 2002). A possible explanation could 
be that there is no need for zinc storage in the mammary gland under conditions of 
zinc deficiency. Zinc bound to MT may undergo exchange reactions transferring 
zinc to other proteins (Klaassen et al., 1999). Cadmium has a higher affinity for 
MT than zinc and the Cd-MT complex is more stable in the tissues. This could 
explain the cadmium-induced increase of zinc in milk in our study, i.e. MT 
binding sites for zinc in the mammary gland were depleted due to cadmium 
uptake, and thus more zinc was available for excretion. Further, the data may 
indicate that MT induction was saturated in the mammary tissue, since there was 
no increase in the fraction of cadmium eluted in the MT fraction in the high 
compared to the low dose group. This was in contrast to the liver, where the 
fraction of cadmium eluted in the MT fraction increased during the whole dose 
range. 21 
To conclude, the results in our study demonstrate a low, but consistent, transfer 
of cadmium via milk to the suckling pup. The uptake and retention of cadmium in 
the mammary tissue was prominent, and a dose-related increase in proportion of 
cadmium in the cytosolic MT–fraction was observed. The role of MT in uptake 
and retention of zinc and cadmium in the mammary epithelial cells remains 
unclear, but it seems probable that MT functions as a storage protein in the tissues. 
 
Cadmium in milk and effects on milk secretion 
109Cd was distributed in fat (46-52%), casein fraction (40-46%), and whey fraction 
(6-8%) in milk (paper I). In human milk significant amounts (15-30%) of copper, 
zinc, calcium and iron are associated with the fat fraction, mainly bound to the 
outer fat globule membrane (Fransson & Lönnerdal 1982, 1984). It has been 
suggested that iron and zinc bind to xanthine oxidase and alkaline phosphatase 
present in the outer fat globule membrane in human milk (Fransson & Lönnerdal 
1982, 1984). Both enzymes are metal-carrying; alkaline phosphatase with four 
specific binding sites for zinc and xanthine oxidase with eight specific binding 
sites for iron per molecule (Rumball & Baker, 1985). Since cadmium is known to 
interact with zinc, it may be speculated that cadmium in the milk fat fraction also 
binds to these enzymes. There were no alterations of protein or lactose 
concentrations in milk following cadmium exposure. Neither were there were any 
effects on DNA or RNA levels or the RNA/DNA ratio, or any abnormalities in the 
histological evaluation of the mammary tissue at any dose level. 
 
The binding of cadmium to the casein fraction might also be explained by the 
similarities between cadmium and zinc. Zinc is bound to the phosphoserine groups 
in casein in the human and bovine milk (Singh et al., 1989). Cadmium also 
interacts with calcium (Goyer, 1997), and since casein is rich in calcium, this 
could also explain the presence of cadmium in the casein fraction. There are large 
interspecies differences in casein concentration in milk. For instance, in human 
milk the casein levels are 2-6 mg casein/ml compared to 60-90 mg casein/ml in rat 
milk (Jenness, 1973; Lönnerdal & Fossum, 1985). Lead is known to be excreted 
via milk in relation to casein concentrations, and consequently, lead excretion 
varies between species pending casein content (Palminger Hallén & Oskarsson., 
1995). Cadmium levels in milk are low in all species investigated; rodents (Lucis 
et al., 1972; Tanaka et al., 1972), sheep (Houpert et al., 1997), cattle (Smith et al., 
1991) and humans (Vuori et al., 1983; Dabeka et al., 1986; Schramel et al., 1988; 
Palminger Hallén et al., 1995; Biego et al., 1998; Rodríguez Rodríguez et al., 
1999), which indicate that the mechanism for cadmium excretion in milk differs 
from lead excretion, despite the high fraction present in the casein fraction in both 
cases.  
 
Cadmium in the whey fraction was low and may partly consist of Cd-MT 
complex. In human breast milk, free from lipid and lipid associated proteins, thus 
corresponding to the casein and whey fractions in our study, cadmium was found 
in the same fractions as the metallothionein standard (Michalke & Schrammel, 
1990). The discrepancy may depend on species differences. 
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Zinc levels in milk were positively correlated to cadmium levels in milk (y = 
0.61x + 9.0; r
2 = 0.26; p = 0.03). Zinc concentrations in milk are highly conserved 
over a wide range of dietary zinc intake in both humans and rodents, indicating 
that zinc transport from the mammary gland to milk is tightly regulated (Kelleher 
& Lönnerdal, 2002). Thus, the small increase in milk zinc concentrations found 
here indicates that cadmium treatment imposed a pathway, although minor, for 
zinc excretion in milk. Excretion of zinc and cadmium in milk in rats may not 
depend on identical excretion mechanisms. After single doses of radioactive 
isotopes of zinc or cadmium, since zinc levels in milk showed a rapid peak and 
decline, compared to cadmium, which was excreted at continuously low levels and 
with a slow decline (Lucis et al., 1972).  
 
The increased zinc excretion in our study may be explained by cadmium-
induced depletion of intermediate intracellular binding sites for zinc, as discussed 
above, preceding the excretion via zinc transporter proteins, as proposed by 
Kelleher & Lönnerdal (2002). Another possibility is that cadmium in the 
mammary gland modulates the zinc transporter proteins. In liver cells it has been 
shown that cadmium and zinc induce mRNAs for ZnT-1, a zinc export protein 
(Langmade et al, 2000), which is also identified in mammary gland (Kelleher & 
Lönnerdal, 2002). However, at present there are no reports on interactions 
between cadmium and ZnT-4, the highly expressed zinc transporter in mammary 
epithelial cells (Huang & Gitschier, 1997).  
 
A significant decrease (p = 0.03) in medium-chain fatty acids (8:0-14:0) and an 
increase in 16:0 (p = 0.007) were observed in milk of rats in the high dose group 
compared to the control group (paper IV). An explanation to this finding could be 
reduced activity of an enzyme specific for the mammary tissue, thioesterase II, 
which contains three cystein residues (Randhawa & Smith, 1987). The medium-
chain fatty acids are synthesised de novo in the mammary epithelial cells through 
the activation of thioesterase II. Thioesterase II terminates the fatty acid chain at 8-
12 carbons. In the absence of thioesterase II, the elongation proceeds to 16 
carbons (Barber et al., 1997). The medium chain fatty acids are considered 
beneficial for the neonate since they are rapidly absorbed in the gastrointestinal 
tract (Williamson, 1985; Hamosh, 1987). Milk from lactating mothers with 
preterm newborns have higher levels of medium-chain and long-chain fatty acids. 
A decrease in medium-chain fatty acid intake of the pups in the present study 
could possibly result in decreased body weight, but no such alterations were seen.  
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Neurochemical effects in sucklings after postnatal cadmium 
exposure via milk 
The serotonergic system was found to be the most susceptible transmitter system 
in developing brain after cadmium exposure (paper III). Serotonin (5-HT)levels in 
cerebral cortex were reduced to approximately 70% of the levels in the control 
group in animals exposed during suckling or during both the suckling and 
postweaning periods. Further, levels of the metabolite of serotonin, 5-
hydroxyindoleacetic acid, were reduced to approximately 60% of the control in 
cerebral cortex and hippocampus in the group exposed during suckling. In 
striatum the pattern was similar to that in the cerebral cortex and hippocampus, but 
the differences between treatment groups did not reach significance. Changes in 
neurotransmitter metabolism in the developing CNS after cadmium exposure have 
been reported, as previously described. In contrast to our results, increased 5-HT 
levels in pup brains were demonstrated after pre- and postnatal cadmium exposure 
(Rastogi et al., 1977; Antonio et al., 1998). The contradicting results may be due 
to differences in experimental design e.g. cadmium dose, timing in age at exposure 
or measurement of outcome, and brain regions investigated. Tyrosine hydroxylase, 
which is the rate limiting enzyme for synthesis of dopamine and noradrenaline, 
was decreased in the cerebral cortex of rats exposed to cadmium during both 
suckling and postweaning. This is in consistency with observations by Gutiérrez-
Reyes and coworkers (1998), who reported a decrease in striatal tyrosine 
hydroxylase activity in newborn rats exposed parenterally to cadmium. There was 
a tendency to decreased noradrenaline levels in cerebral cortex and hippocampus 
that could be a result of reduced activity of tyrosine hydroxylase, but the findings 
could also be due to a reduced number of noradrenergic nerve terminals. 
Dopamine levels were not significantly altered by treatment. No changes in 
acetylcholine levels were found, in spite of a decrease of acetylcholine esterase in 
the cerebral cortex of rats exposed to cadmium during both suckling and 
postweaning. A cadmium-induced reduction in synthesis or transport of 
acetylcholinesterase could explain the observation. There were no alterations in 
mRNA levels of BDNF, NT-3, or trkB. No morphological alterations were 
observed. 
 
It can be concluded that the serotonergic pathway was the most sensitive to 
cadmium exposure via milk in the neonate during the suckling period. It can be 
noted that compared to previous reports on neurochemical effects after postnatal 
cadmium exposure, the cadmium dose in the present study was very low, i.e. 0.8-
1.2 mg Cd/kg/day p.o., to the lactating dam. It can also be concluded that the 
indications of cadmium altering CNS neurotransmitter metabolism during 
development, need further exploration. 
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Neurobehavioural effects in rats after cadmium exposure via 
milk 
Cadmium-related increase in locomotor activity was observed during the initial 
periods of the spontaneous locomotor test (paper III). Ambulation data are 
illustrated in Figure 4a. Repeated measures ANOVA showed that the between-
group main effect for ambulation was significant >F(2,27)= 5.3; p=0.011@. Also, 
significant treatment by time interactions were found for ambulation >F(10,135)= 
5.4; p<0.0001)@, small movements >F(10,135)= 3.2; p<0.0001@, rearing 
>F(10,135)= 6.0; p<0.0001@, total activity >F(10,135)= 6.2; p<0.0001)@. Multiple 
comparisons between groups within each 10 minute period, showed that the high 
dose group were significantly more active than the control group during the initial 
20 minutes of the test, with the exception of rearing, for which the outcome was 
different from control in the first 10 minutes only. Cadmium concentrations in the 
kidney were used as biomarker for biological dose, see discussion below. By using 
linear regression analysis the individual data from all groups were used, and a 
significant linear relationship was found between outcome in the activity test and 
cadmium levels in kidneys of pups (p < 0.01; R
2 ranging between 0.26-0.32 for 
ambulation, small movements and total activity). In Figure 4b, linear regression 
analysis of the ambulation data is shown. There was no indication of a threshold 
level and we conclude that hyperactivity was correlated to the biological cadmium 
dose. No alterations in learning, memory or anxiety responses were found. In 
contrast, decreased learning ability as well as hypoactivity was reported in weaned 
rats perinatally exposed to cadmium for 30 days (Gupta et al., 1993). The 
cadmium exposure used in the present study is markedly lower, which may 
explain why no effects on learning were observed. The behavioural response is 
similar to what Rastogi and coworkers described (1977) after repeated oral 
exposure in neonatal rats, which could indicate that the observed neurobehavioural 
effects are induced by cadmium directly, and not mediated by maternal effects 
resulting in altered milk composition. However, in order to elucidate this, a study 
exposing neonates orally to cadmium is necessary. No differences were found 
between groups in the outcome of the rotarod test when the first and second trials 
were analysed separately.  
  
In conclusion, this study indicates that neurobehavioral effects may occur in the 
offspring of lactating dams at lower cadmium exposure levels than previously 
reported.  
 
Body weights 
In paper I and II, there were no significant differences in body weights between 
the groups of pups or dams. In paper III there were no differences in body weights 
in dams. In the litters, a significantly lower body weight was recorded at one 
occasion, postnatal day (PND) 17, in the high dose group compared to low dose 
and control groups. At PND 1, 4, 7, 10, and from PND 24 and onwards, there 
were no significant alterations in body weights between the treatment groups. It is 
known that malnutrition resulting in a persistent and more severe decrease in body 
weight is accompanied by increased activity in pups (Almeida et al., 1993). ￿
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Figure 4a. Ambulation performance in the spontaneous locomotor activity test at PND 39-
42 (n=10). Rats were exposed to cadmium during suckling via cadmium exposed dams until 
PND 17. The dams were exposed to cadmium chloride in drinking water at doses of 0, 5 or 
25 mg Cd/l. Results are presented as mean values ± SD 
a Significantly different from control p< 0.01, 
b Significantly different from control p< 0.01 
 
b) The relationship between ambulation performance in the spontaneous locomotor activity 
test and individual Cd concentrations in pup kidney (µg/kg w.w.) sampled immediately 
after completion of the test. Pups were exposed to cadmium during suckling via cadmium 
exposed dams until PND 17. The dams were exposed to cadmium chloride in drinking 
water at doses of 0, 5 or 25 mg Cd/l. The relationship between ambulation and Cd in pups 
kidney is described by the equation: y = 43.7 + 2.9x, p = 0.001 and r
2 = 0.32. Diamonds: 
control group; open circles: low dose group; filled circles: high dose group. 
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The observed transient reduction in body weights by 7% on PND 17 in the present 
study is not a plausible explanation for the increased activity in exposed pups. In 
paper IV no body weight differences were observed in the female pups at sacrifice 
on PND 19.  
 
Possible explanations of the CNS effects 
Cadmium concentrations in the brain of pups were below the detection limit, i.e. 
<0.004 µg/g w.w. (paper II). Still, there were pronounced reductions in serotonin 
and its metabolite 5-hydroxyindoleacetic acid in cerebral cortex and hippocampus 
of rats exposed to cadmium during suckling. There may be two reasons for these 
findings: either the developing central nervous system is very sensitive to 
cadmium, or cadmium exerts some effect on the milk composition affecting the 
newborn. The non-detectable cadmium concentrations in brain are in contrast to 
other studies, where increased levels of cadmium are reported in brain after 
perinatal cadmium exposure (Gulati et al., 1986; Gupta et al., 1993; Gupta et al., 
1995; Antonio et al., 1998; Gutiérrez-Reyes et al., 1998; Antonio et al., 1999; 
Méndez-Armenta et al., 2001). However, there are differences in study design, 
e.g. cadmium dose, route and duration of exposure, which can explain this. Also, 
we chose to withdraw the source of exposure, namely cadmium in the drinking 
water, from postnatal day 17 until weaning. This was done in order to avoid the 
suckling pups to be directly exposed to cadmium by drinking water. Quality 
assurance of the cadmium analyses is also an important issue when interpreting the 
data, and information of this is often lacking. In paper II, analyses of reference 
material resulted in higher cadmium levels than the certified value, indicating 
contamination problems in these samples or too high signals. Anyway, the 
discrepancy does not imply that the cadmium concentrations in the brains were 
underestimated in this experiment (paper II). Altogether, from the present work 
(paper I), and previously reported studies it can be concluded that cadmium is 
distributed to the developing brain in very small amounts.  
 
Zinc levels in brain of pups were in line with previously reported levels (Kishi et 
al., 1982; BaraĔski,1986; Gupta & Shukla, 1996; Erickson et al., 1997), and not 
altered by cadmium exposure (paper IV). This is in contrast to observations made 
by Gupta & Shukla (1996) and BaraĔski (1986) after cadmium exposure. 
However, they exposed the animals prenatally which may explain the difference. 
Also, the distribution of zinc in brain seems to be age dependent. In mice, zinc 
levels are higher in hippocampus than in other brain regions (Shin-ichi et al., 
1997). On the other hand, in brains of 22 day old rats zinc was evenly distributed, 
while zinc levels were higher in hippocampus than in other brain regions in adult 
rats (Kishi et al., 1982). In the present study, zinc was analysed in whole brain at 
postnatal day 20 and at 6 weeks of age, and the zinc concentrations were 
remarkably constant in exposed and control groups as well as in both age groups. 
This indicates that cadmium treatment did not cause any change in whole brain or 
regional zinc levels.  
 
The fatty acid composition in the brains of pups was characterised by a low 
inter-individual variation. There were no major changes in the fatty acid 
composition due to cadmium treatment. Levels of DHA were not altered. The (n-27 
6)/(n-3) ratio was not altered by treatment, indicating that the activity of the rate 
limiting ǻ-6 desaturase was not affected. However, a small but significant increase 
in the proportion of 20:3(n-6) was observed, 0.84% ± 0.04 and 0.78% ± 0.01, in 
the high compared to the control group, respectively (p = 0.037). Despite 20:3(n-
6) being a precursor to AA, there were no alterations in AA levels in the brain. It 
may be speculated that increased amounts of AA are actually synthesised, the 
turnover of AA in brain phospholipids is indeed very rapid (Washizaki et al 
(1994), and further metabolised to its eicosanoid metabolites with the formation of 
fatty acid radicals and oxygen radicals. It is known that AA is involved both in 
processes leading to tissue damage and in beneficial biological actions in the brain 
(Katsuki and Okuda, 1995). Thus, highly controlled levels of AA are essential for 
the physiological functions of the nervous system. However, it can not be 
excluded that the significant effect on 20:3(n-6) is spurious and further 
investigations are needed to confirm the results and elucidate the mechanism. 
 
Further studies are needed in order to clarify this issue. For instance, analyses of 
eicosanoid metabolites, or studies of the activity of enzymes in the AA metabolic 
pathway should be investigated in hippocampus and cerebral cortex in the 
developing brain after cadmium exposure.   
 
Cadmium exposure and biological dose in lactating rats and 
their offspring  
Cadmium doses used in these studies have generally been low. Kidney cadmium 
levels have been used as a marker for biological dose in adults. However, renal 
function is not fully developed at birth in humans or rodents. Glomerular function 
develops to adult capacity during the first 6 months of life in humans, and adult 
renal tubuli function is reached at approximately 1 year of age (Alcorn & 
McNamara, 2002). Likewise, adult glomerular filtration rate is not reached in 
young rats until at 7 weeks of age (Provoost et al., 1983; Fleck, 1992).  
 
The exposure regimens and the resulting cadmium kidney levels in dams and 
pups are shown in Table 1. Since one of the endpoints of using animal models in 
toxicology is extrapolation to humans, a comparison to human exposure and 
cadmium kidney levels is also made in Table 1. Cadmium intake via food is 
approximately 10-20 µg/day in most Western diets, which corresponds to 
approximately 0.1-0.4 µg Cd/kg body wt. per day (WHO, 2001). One might argue 
that the doses given in the present work are high compared to human cadmium 
intake via food. On the other hand, in most previous studies on developmental 
neurotoxicity of cadmium, even higher doses and often parenteral administration 
have been used.  
 
The cadmium exposure in the present study could also be compared by means of 
the kidney cadmium concentrations. Histopathological and biochemical changes in 
rat renal tubules are reported at Cd levels in rat kidney ranging from 40-200 mg 
Cd/kg wet weight (WHO, 1992). This should be compared with the observed CNS 
effects in offspring reported in the present study, at kidney Cd levels of 4-13 mg 
Cd/kg wet weight in lactating dams after 3 weeks of oral Cd exposure. It should 
also be emphasised that the pups have been exposed to, and absorbed, much lower 28 
levels of cadmium. Thus, the results indicate that neurochemical and 
neurobehavioural effects during development may be a more sensitive target for 
cadmium toxicity in animal models than renal dysfunction.  
 
Cadmium levels in rat milk obtained in the present study were 0.10 - 5.4 ng/ml 
(paper I). In human milk similar cadmium levels have been reported: < 0.002-4 
ng/ml (Vuori et al., 1983; Dabeka et al., 1986; Biego et al., 1988; Schramel et al., 
1988; Palminger Hallén et al., 1995; Rodríguez Rodríguez et al., 1999) giving 
support for the view that the cadmium exposure in the present study is a low dose 
regimen.   
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Concluding remarks 
 
Using radioactive 
109Cd, it was shown that cadmium is transferred via milk to the 
pup. A strong correlation between cadmium concentration in pup kidney and 
cadmium concentration in the kidney and milk of the lactating dam was found, 
showing that cadmium is transferred via milk to the suckling pup. In addition, this 
indicates that cadmium kidney concentrations can be used as a biomarker for 
biological dose in pups, despite immature renal function.  
 
Autoradiography showed a high uptake and retention of cadmium in the 
mammary epithelial cells during lactation. In lactating rat mammary tissue 
cadmium was found in a peak eluted at a similar molecular size as metallothionein 
after gel filtration. The data thus indicate that cadmium to a large extent is bound 
to metallothionein in the cytosol of the mammary epithelial cells. This could 
explain the high cadmium concentration in the mammary gland and the low 
cadmium concentration in the milk. In rat milk, cadmium was mainly bound to the 
fat and casein fractions.  
 
In pups with brain cadmium levels below the detection limit, a marked decrease 
in serotonin and its metabolite 5-hydroxyindoleacetic acid was observed in 
cerebral cortex and hippocampus. The pups were exposed to cadmium via the milk 
from exposed dams. Further, there was a tendency to decreased levels of 
noradrenaline but the differences did not reach significance.  
 
Pups exposed to Cd via milk from lactating rats showed increased spontaneous 
locomotor activity during the first period of the test compared to control. A 
positive linear correlation was found between initial spontaneous locomotor 
activity and kidney cadmium concentrations in the pups. Outcomes in tests 
measuring learning, memory, or anxiety were not altered by treatment.  
 
Cadmium exposure altered the fatty acid composition in the liver and milk of the 
dams, and a minor modification was seen in the brain of the pups. The long-chain 
polyunsaturated fatty acids, which are important for normal development of the 
CNS, were unaltered, as were zinc levels in the brain. The results showed that 
cadmium treatment decreased the levels of medium chain fatty acids in milk while 
the levels of 16:0 were increased. This indicates that cadmium may inhibit the 
activity of thioesterase II present in the cytosol of the rat mammary epithelial cells. 
The Cd-induced CNS effects in offspring can probably not be due to changes in 
fatty acid composition or zinc levels in brain. It seems likely that the CNS effects 
are due to a direct effect of Cd in the brain. 
 
Overall, the results indicate that neurochemical and neurobehavioral effects 
during development may be a more sensitive endpoint for cadmium toxicity in 
animal models than renal dysfunction. In most studies on cadmium neurotoxicity, 
high doses and parenteral exposure routes have been applied. Further research in 
developmental neurotoxicity of cadmium at relevant biological doses, as well as 
elucidation of the mechanisms for the observed effects would be of importance for 
risk assessment of cadmium in infants and children.  
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